Filing Details

Accession Number:
0001062993-22-023333
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-05 16:36:52
Reporting Period:
2022-12-01
Accepted Time:
2022-12-05 16:36:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1744659 Akero Therapeutics Inc. AKRO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1869027 Ltd International Ezbon 3076 Sir Francis Drake'S Highway
Road Town
Tortola D8
No No No Yes
1869057 Ltd Enterprise Horizon Blue 3076 Sir Francis Drake'S Highway
Road Town
Tortola D8
No No No Yes
1869331 Ltd Trustees Montrago 195 Arch. Makarios Iii Ave
Neocleous House
Limassol G4 3030
No No No Yes
1869333 Trust Skorpios 195 Arch. Makarios Iii Ave.
Neocleous House
Limassol G4 3030
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-12-01 1,636,000 $43.50 3,271,829 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. Blue Horizon Enterprise Ltd. ("Blue Horizon") is the direct owner of 2,346,298 shares of the issuer's common stock and Ezbon International Limited ("Ezbon") is the direct owner of 925,531 shares of the issuer's common stock. Skorpios Trust ("Skorpios") is the sole owner of each of Blue Horizon and Ezbon. Montrago Trustees Limited ("Montrago Trustees") is the corporate trustee of Skorpios Trust. Each of Blue Horizon and Ezbon disclaim beneficial ownership of the shares of the issuer's common stock held by the other, and each of Skorpios Trust and Montrago Trustees disclaim beneficial ownership of the issuer's securities except to the extent of their pecuniary interest therein.